Innovator IBD Breakout Opportunities ETF (NYSEARCA:BOUT) Sees Large Decline in Short Interest

Innovator IBD Breakout Opportunities ETF (NYSEARCA:BOUT) saw a significant decrease in short interest during the month of August. As of August 14th, there was short interest totaling 400 shares, a decrease of 54.4% from the July 30th total of 877 shares. Approximately 0.1% of the company’s stock are sold short. Based on an average daily volume of 2,137 shares, the short-interest ratio is currently 0.2 days.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently modified their holdings of the stock. Osaic Holdings Inc. lifted its holdings in shares of Innovator IBD Breakout Opportunities ETF by 39.7% during the second quarter. Osaic Holdings Inc. now owns 2,102 shares of the company’s stock worth $77,000 after purchasing an additional 597 shares during the period. Comprehensive Wealth Management LLC increased its stake in Innovator IBD Breakout Opportunities ETF by 122.0% in the 4th quarter. Comprehensive Wealth Management LLC now owns 23,403 shares of the company’s stock valued at $850,000 after buying an additional 12,859 shares during the period. Finally, Susquehanna International Group LLP increased its stake in Innovator IBD Breakout Opportunities ETF by 42.6% in the 3rd quarter. Susquehanna International Group LLP now owns 26,176 shares of the company’s stock valued at $1,020,000 after buying an additional 7,817 shares during the period.

Innovator IBD Breakout Opportunities ETF Price Performance

Shares of BOUT traded down $0.76 during midday trading on Friday, reaching $44.16. 312 shares of the stock were exchanged, compared to its average volume of 3,782. The business’s 50-day moving average price is $46.35 and its 200 day moving average price is $44.12. Innovator IBD Breakout Opportunities ETF has a twelve month low of $35.05 and a twelve month high of $49.41. The company has a market capitalization of $15.46 million, a price-to-earnings ratio of 28.69 and a beta of 1.04.

Innovator IBD Breakout Opportunities ETF Company Profile

The Innovator IBD Breakout Opportunities ETF (BOUT) is an exchange-traded fund that is based on the IBD Breakout Stocks Total Return index. The fund tracks an index of US-listed stocks that are likely to breakout, as determined by technical analysis. Holdings are weighted by a mix of fundamental and technical factors BOUT was launched on Sep 13, 2018 and is managed by Innovator.